Concepedia

Aki Aoyama

AA

Statistics

Publications

4

Citations

369

H-Index

4

Active since

2013

Affiliations

The University of Tokyo(Current)

Aki Aoyama is an author at The University of Tokyo specializing in tumor biology, pharmacotherapy, and medicinal chemistry.

Top concepts

Publications per year

2013–2022

4

Publications

4

Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition

Ryohei Katayama, Aki Aoyama, Takao Yamori et al. · Cancer Research · 2013 · 208 citations · Full text

, , +18

<i>APC</i> Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer

Noritaka Tanaka, Tetsuo Mashima, Anna Mizutani et al. · Molecular Cancer Therapeutics · 2017 · 81 citations

Tivantinib (ARQ 197) Exhibits Antitumor Activity by Directly Interacting with Tubulin and Overcomes ABC Transporter–Mediated Drug Resistance

Aki Aoyama, Ryohei Katayama, Tomoko Oh‐hara et al. · Molecular Cancer Therapeutics · 2014 · 60 citations

Different Spatial and Temporal Roles of Monocytes and Monocyte-Derived Cells in the Pathogenesis of an Imiquimod Induced Lupus Model

Atsushi Nomura, Miho Mizuno, Daisuke Noto et al. · Frontiers in Immunology · 2022 · 20 citations · Full text

1–4 of 4